Literature DB >> 3521519

Chlorzoxazone hepatotoxic reactions. An analysis of 21 identified or presumed cases.

B J Powers, E L Cattau, H J Zimmerman.   

Abstract

A drug rechallenge proved chlorzoxazone to be hepatotoxic in a patient who had been treated with a combination of it and acetaminophen (Parafon Forte) for several months. Failure to demonstrate a toxic response to acetaminophen coupled with a dramatic response to a single dose of chlorzoxazone implicated chlorzoxazone as the hepatotoxic agent. A review of US Food and Drug Administration records and cases reported in the medical literature disclosed 23 cases of chlorzoxazone-associated hepatotoxic reactions occurring since 1970. These cases were examined in terms of age, duration of therapy, other confounding etiologic factors, and ultimate outcome. There were two deaths involving hepatic failure. Reports of adverse reactions among six commonly used analgesic-muscle relaxants in Sweden have indicated a low, but comparatively greater, incidence of hepatotoxic reactions associated with a chlorzoxazone-containing compound.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3521519     DOI: 10.1001/archinte.146.6.1183

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  5 in total

1.  Chlorzoxazone, an SK-type potassium channel activator used in humans, reduces excessive alcohol intake in rats.

Authors:  F Woodward Hopf; Jeffrey A Simms; Shao-Ju Chang; Taban Seif; Selena E Bartlett; Antonello Bonci
Journal:  Biol Psychiatry       Date:  2010-12-31       Impact factor: 13.382

2.  Chlorzoxazone as a cause of acute liver failure requiring liver transplantation.

Authors:  James Jackson; Frank A Anania
Journal:  Dig Dis Sci       Date:  2007-03-28       Impact factor: 3.199

3.  Computer-aided identification of recognized drugs as Pseudomonas aeruginosa quorum-sensing inhibitors.

Authors:  Liang Yang; Morten Theil Rybtke; Tim Holm Jakobsen; Morten Hentzer; Thomas Bjarnsholt; Michael Givskov; Tim Tolker-Nielsen
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

4.  To compare the efficacy and safety of fixed dose combination of thiocolchicoside and aceclofenac versus chlorzoxazone, aceclofenac and paracetamol in patients with acute lower backache associated with muscle spasm.

Authors:  Sanjeev Kumar; Seema Rani; Ramchander Siwach; Prem Verma
Journal:  Int J Appl Basic Med Res       Date:  2014-07

5.  Identification of drug combinations on the basis of machine learning to maximize anti-aging effects.

Authors:  Sun Kyung Kim; Peter C Goughnour; Eui Jin Lee; Myeong Hyun Kim; Hee Jin Chae; Gwang Yeul Yun; Yi Rang Kim; Jin Woo Choi
Journal:  PLoS One       Date:  2021-01-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.